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Abstract
Introduction
Despite availability of screening for diabetic retinopathy, testing is
underused by many low-income and racial/ethnic minority pa-
tients with diabetes. We examined perceived barriers to diabetic
retinopathy screening among low-income patients and their health
care providers and provider staffers.
Methods
We collected survey data from 101 patients with diabetes and 44
providers and staffers at a safety-net clinic where annual diabetic
retinopathy screening rates were low. Barriers specified in the sur-
vey were derived from the literature.
Results
Patients surveyed (mean [standard deviation] age, 54.0 [7.7] y;
41% were male)  were primarily  Hispanics  (70%) and African
Americans (27%) of low socioeconomic status. Overall, 55% of
patients received diabetic retinopathy screening in the previous
year. Patients who could not explain why this screening is needed
reported more barriers than patients who could (2.5 vs 1.4 barriers,
P = .02). Fewer patients reported that they experienced barriers
such as transportation (15%), language issues (15%), cultural be-
liefs or myths (4%), denial (8%), and fear (5%), which providers
and staffers considered very or extremely important (all P < .001).
Financial burdens (26%) and depression (22%) were most com-
monly reported by patients as barriers, yet providers and staffers
did not rate these barriers as important, P < .001.
Conclusion
Patients and health care providers had markedly divergent percep-
tions of barriers to diabetic retinopathy screening. Patients with
poor understanding of the need for screening were more likely to
report such barriers. These results suggest a need for active com-
munity engagement to find key elements for education programs
and other interventions to increase rates of diabetic retinopathy
screening, particularly among low-income, minority populations.
Introduction
Diabetes is a major cause of vision impairment and blindness in
the working-age population (18–65 y) in the United States and
worldwide (1,2). More than a third of people with diabetes world-
wide have some form of diabetic retinopathy (DR), and 10% have
sight-threatening DR (3).  The landmark Diabetes  Control  and
Complications Trial determined intensive glycemic control in dia-
betes reduced the risk of development and progression of diabetic
retinopathy by 34% (4). Conversely, increased hemoglobin A1C
levels have been directly related to development of complications
of diabetes, including DR (5).
Early detection and treatment of sight-threatening DR is best ac-
complished by routine screening as recommended by the Ameri-
can Diabetes Association and the American Academy of Ophthal-
mology (6,7). Yet, low use of DR screening is common, espe-
cially among low-income patients who are racial/ethnic minorities.
In  2002,  the  DR screening  rate  for  working-age  adults  in  the
United States was 56%. By 2009, this rate had increased to 59%
for white patients with diabetes while the rate for minority pa-
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tients with diabetes dropped to 49% (8). However, national data,
such as data from the National Health and Nutrition Examination
Survey and the National Health Interview Survey, indicate that
people without a high school diploma or people at lower income
levels have significantly higher rates of DR (9). In addition, low
screening rates for DR in racial/ethnic minority patients demon-
strate an association with a lack of understanding that diabetes can
lead to complications such as DR (10). These findings indicate a
greater need for increased DR screening and patient education
among low-income minority patients (5,11).
Research suggests that multiple patient barriers to DR screening
exist, including poor access to care, lack of time, out-of-pocket ex-
penses, insufficient patient knowledge or awareness of DR, and
lack of care coordination (12–17). However, few studies have ex-
amined whether patient barriers are recognized and understood by
their health care providers, which is an important step toward im-
proving patient screening compliance and diabetes outcomes, par-
ticularly among low-income and minority patients with low annu-
al DR screening rates.
To fill this knowledge gap, we identified and compared perceived
barriers to DR screening among low-income patients and their
health care providers and provider staffers. To assess what barri-
ers might be relevant without cost as a consideration, we studied
patients in a setting where retinal screening was free of charge.
Our findings may inform interventions to remove or ameliorate
barriers to recommended diabetes care among vulnerable patient
populations.
Methods
A cross-sectional survey was designed to capture all potential bar-
riers to retinopathy screening perceived by patients and by pro-
viders and their staffers. Specific barriers in the survey were iden-
tified and derived from the literature (12–17). Participants were
also asked to report any additional barriers not listed in the survey.
This anonymous patient survey was pilot-tested and was finalized
on the basis of patient feedback to ensure all questions were cul-
turally appropriate and were understood.
Patients were recruited from a large safety-net health center in
South Los Angeles that serves predominantly low-income minor-
ity patients. The inclusion criteria for patients were that patients be
aged 18 years or older and have a clinical diagnosis of diabetes.
Data were collected anonymously from patients, providers, and
staffers from December 2014 through January 2015. By using a
convenience sample method, the survey team approached 110 pa-
tients waiting to be seen in the family medicine, internal medicine,
or diabetes clinics and all 55 providers and provider staffers work-
ing in these 3 clinics, which comprise most of the health center.
One hundred and one patients with diabetes and 44 providers and
staffers completed the survey, resulting in a response rate of 92%
and 80%, respectively. About two-thirds of the patient surveys
were completed in Spanish and translated to English.
Patients were asked to rate any given barrier that “would delay or
prevent you from getting your screening/test for diabetic eye dis-
ease” on a 5-point Likert scale with choice options of  “strongly
disagree,” “disagree,” “neither agree or disagree,” “agree,” and
“strongly agree.” Health care providers and their staffers were
asked to “check how important it is to address the following po-
tential barriers for patients to receive retinal eye screening at [clin-
ic]” on a 5-point Likert scale with choice options of “not at all im-
portant,” “slightly important,” “moderately important,” “very im-
portant,” and “extremely important.”
We used Pearson’s χ2 to compare differences in perceived barriers
to DR screening between patients and providers and staffers. If a
patient agreed or strongly agreed with a barrier, we considered the
patient as having identified that as a barrier. We examined wheth-
er the number or type of barriers reported differed by patient char-
acteristics by using the 2-sided student t test. All statistical analys-
is was conducted in Stata, version 13 (StataCorp LP). The study
was approved by the institutional review board of the Los Angeles
Biomedical Research Institute.
Results
Patients surveyed (mean [standard deviation] age, 54.0 [7.7] y;
41% were  male)  were  primarily  Hispanic  (70%)  and  African
American (27%) of low socioeconomic status (Table). Half repor-
ted an annual household income of less than $10,000, and 56% in-
dicated they were not working. Six in 10 patients either were not
married or did not live with a partner, and only one-third had a
high school or general equivalency diploma or more education.
Most had had diabetes for more than 5 years; duration of diabetes
was more than 10 years in 40% of patients and from 6 to 9 years in
27%.
Overall,  55% of  patients  reported  that  they  had  received  DR
screening in the previous year. This was despite the fact that 93%
of patients were aware that  diabetes can cause vision loss and
blindness and despite 77% of patients having had their physician
recommend they have DR screening. Lack of DR screening in the
previous year was not associated with whether patients reported
any barriers.
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Further evaluation showed that 31% of patients reported no per-
ceived barriers, 26% acknowledged 1 barrier, and 44% reported 2
or more barriers. Most commonly reported barriers were depres-
sion (22%) and financial  problems (26%); 14% reported both.
Language issues, lack of transportation, and lack of time were
each reported as barriers by 15% of patients.
Employed patients were more likely to report lack of time to be a
barrier than those not employed (23% vs 7%, P = .03). In general,
women reported more barriers than men (1.9 vs 1.2, P = .06). Pa-
tients  who could not  adequately explain why DR screening is
needed (n = 21) reported more barriers than patients who could
(2.5 vs 1.4, P = .02).
The comparison of 8 barriers rated by patients versus those rated
by providers and their staffers revealed markedly divergent per-
ceptions between the 2 groups (Figure 1, Figure 2) (all P < .001).
Only a small fraction of patients reported that they experienced
barriers  such  as  transportation  (15%),  language  issues  (15%),
denial (8%), fear (5%), or cultural beliefs that DR screening is
harmful (4%) that most providers and staffers thought to be very
or extremely important (P < .001). In contrast, the barriers most
commonly reported by patients — financial burdens (26%) and
depression (22%) — were not considered as important as other
barriers by providers and staffers (P < .001). Furthermore, even
though 93% of patients were aware diabetes can cause vision loss
and blindness, in contrast, 70% of providers and staffers rated lack
of such awareness as “extremely important.” Similarly, 77% of pa-
tients were aware of a DR screening program in the clinic, where-
as  more than half  of  providers  and staffers  rated lack of  such
awareness as “extremely important” (P < .001).
Figure  1.  Perceived logistic  and external  barriers  to  diabetic  retinopathy
screening, Los Angeles, California, 2014–2015. Patients were asked to rate
reasons that “would delay or prevent you from getting your screening/test for
diabetic eye disease.” Health care providers and their staffers were asked to
rate “how important it is to address the following potential barriers for patients
to  receive  retinal  eye  screening”  at  the  clinic.  All  P  <  .001.  Barriers  are
ordered  in  descending  order  by  how  frequently  they  were  identified  by
patients.
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Figure  2.  Perceived  potential  internal  barriers  to  diabetic  retinopathy
screening, Los Angeles, California, 2014–2015. Patients were asked to rate
reasons that “would delay or prevent you from getting your screening/test for
diabetic eye disease.” Health care providers and their staffers were asked to
rate “how important it is to address the following potential barriers for patients
to  receive  retinal  eye  screening”  at  the  clinic.  All  P  <  .001.  Barriers  are
ordered  in  descending  order  by  how  frequently  they  were  identified  by
patients. Abbreviation: DR, diabetic retinopathy.
 
Discussion
Although most patients in this study (93%) understood that dia-
betes can lead to eye disease and three-quarters received a physi-
cian recommendation for DR screening, the annual screening rate
was only 55%, comparable to previously reported rates for this
population (8,18). This low screening rate confirms the suitability
of this group of patients to represent the low-income, minority pa-
tient population we were studying, many of whom did not use dia-
betes retinal screening despite having knowledge of its import-
ance. The study goal was not only to understand patient barriers
but also to assess provider understanding of their patients’ barri-
ers. Recent meta-analysis showed interventions involving shared
decision making between patients and physicians might benefit
disadvantaged patients to a greater extent than patients of higher
socioeconomic status, particularly if these interventions were ad-
equately tailored to the specific needs of the patient groups (19).
These low screening rates may be partly due to providers’ poor
understanding of how patients perceive barriers to DR screening,
as demonstrated in the study.
Our findings show that provider and staffer perceptions of barri-
ers to DR screening were remarkably different from those of their
patients. Given that 77% of patients in the study had received a
physician’s recommendation for DR screening, this vast differ-
ence suggests a lack of high-quality patient–provider communica-
tion regarding patient barriers to DR screening during the referral
process. In particular, financial burden and depression were most
often reported by patients but deemed less important by providers
and staffers than other barriers. There was no direct out-of-pocket
expense for DR screening at the safety-net health center where the
study was conducted. This may explain why providers and staffers
did not think financial burden was a barrier. However, 26% of pa-
tients perceived it so, suggesting that hidden costs may be high.
Sloan et al presented an economic framework for nonmonetary
costs of DR screening, such as perceived rate of vision change
(very slow, if at all), the estimated functional vision loss from lack
of timely action, and perceived effectiveness of any intervention
(20).  These factors may have influenced patients’ perceptions.
Other considerations may also have been opportunity costs, such
as long waits at clinics and duration of the screening procedure,
which disproportionately affect minority patients, are potentially
correctible, and warrant further investigation (21).
Financial loss from time off work likely also affects patients who
are employed, particularly those without a flexible work schedule.
Depression was the other common barrier reported by patients.
Providers and staffers did not perceive depression as important,
but the barrier is plausible given its high prevalence in patients
with diabetes (22–24). In addition, depression has been associated
with increased severity of diabetes complications, including retin-
al  abnormalities.  Even  after  accounting  for  blood  pressure,
smoking history, and other factors, patients with diabetes and de-
pression have wider retinal arterioles than patients with diabetes
without depression (25). This finding is a possible early indicator
of microvascular disease that precedes typical findings of diabetic
retinopathy, which suggests a more immediate need for timely DR
screening for patients with diabetes and depression. Furthermore,
60% of patients in our study did not have a spouse or live-in part-
ner. For them, depression may be a more critical barrier because of
inadequate family support for diabetes care. Low levels of social
support have been implicated in low screening rates for cardiovas-
cular conditions (26). A similar phenomenon may be occurring in
patients with diabetes.
Lack of time is another barrier of interest, especially affecting pa-
tients who were employed. Given low levels of household income
reported in the survey, employed patients in our study likely held
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nonmanagerial jobs with inflexible time schedules, making medic-
al appointments difficult to arrange. To facilitate the process, DR
screening was provided in the primary care setting where the study
took place. But it generally required a separate referral and ap-
pointment, which may make it challenging for these patients to use
the service.
The survey also revealed a connection between lack of under-
standing of the need for DR screening and the number of reported
barriers in the patient group. This association between the ability
to understand the need for a procedure and perception of barriers
suggests that targeted education might be helpful to increase DR
screening rates and lower perception of barriers. The goal is in-
creased patient understanding of DR screening and therefore its
benefit. Perceived benefit is associated with greater likelihood of
compliance  with  procedures  (27),  perhaps  by  influencing  the
risk–benefit calculation. Along with perceived benefit, perceived
priority of DR screening is probably also a factor. A recent study
incorporated the Health Belief Model construct into a large pa-
tient survey and found that patient-held health beliefs were strong
predictors of their adherence to DR screening, including whether
the  patient  thought  a  DR screening  was  a  “top  priority”  (17).
Coupled with a lack of knowledge among minority patients as to
whether inadequate diabetes control leads to complications such as
DR (10), disadvantaged patients may have false perceptions re-
garding the importance or priority of DR screening. Education that
aims to improve diabetes knowledge and self-management skills
among patients is crucial in helping them understand the import-
ance of adequate diabetes care, including prevention of diabetes-
related complications, such as timely DR screening (5,11,28).
The 31% of patients who reported no barriers did not show higher
rates of DR screening, suggesting that patients might be unaware
of all the barriers they face. It is also possible some barriers were
not identified by our literature-based survey. Most providers and
staffers rated all barriers as important. This suggests that the barri-
ers identified in the literature reflect the perceptions of providers
more than that those of patients, causing potential provider bias in
surveys. Further supporting the notion that DR screening surveys
may be inadequate in capturing patient perceptions is the large dis-
crepancy between DR screening rates of African American and
Hispanic patients, which could not be explained by any difference
in reporting of barriers (29).
A limitation of this study is that in an effort to keep the survey
succinct we did not ascertain whether the patients had had type 1
or type 2 diabetes. Because of the sample size, there would not
have been enough power to differentiate responses between pa-
tients with type 1 and type 2 diabetes. However, it is likely that
95% of the surveyed patients had type 2 diabetes, given its estim-
ated prevalence in minority populations. Another limitation is that
the survey data were collected in a clinic; thus, we were unable to
capture the perspectives of patients who may not regularly attend
clinic visits. Qualitative or quantitative differences may exist in
perception of barriers in patients lost to follow up or not attending
clinic visits for other reasons. Those patients might perceive dif-
ferent types of barriers, or the same types of barriers, to a greater
extent than the patients surveyed. Future research should engage
patient communities to better capture perceived barriers and help
understand what could improve DR screening rates among low-in-
come minority patients, taking into account their unique medical
needs.
Many barriers  to  DR screening acknowledged by low-income
minority patients were anticipated, but the striking divergence
between patient perception and provider and staffer perception of
their importance was not. The lack of agreement between patients’
perceived barriers and provider and staffers’  understanding of
those same barriers indicates need for more effective patient–pro-
vider communication and for patient feedback on health care de-
livery systems. Heightened awareness of depression and its im-
pact on DR screening rates among low-income minority patients
with diabetes is also key to improving their use of DR screening.
In addition, a lack of knowledge of the importance of DR screen-
ing might prevent patients from identifying barriers that prevent
them from adhering to secondary diabetes prevention, such as DR
prevention and detection. Thus, patient education targeting dia-
betes knowledge and self-management is also crucial.  Overall,
these findings highlight the importance of engaging both minority
patient communities and their health care providers in efforts to in-
crease DR screening rates and prevent blindness.
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Table
Table. Demogrpahic Characteristics of Participants (N = 101), Study of Barriers to Diabetic Retinopathy Screening in a Safety-Net Health Center in South Los
Angeles, California, 2014–2015
Characteristic n (%)a
Age, y, mean (SD) 54.0 (7.7)
Male 41 (40.6)
Race/ethnicity
Hispanic 71 (70.3)
African American 27 (26.7)
Other 3 (2.0)
Marital status
Single 37 (36.6)
Married or living with a partner 41 (40.6)
Widowed/divorced/separated 23 (22.8)
Employment status
Employed/self-employed 44 (43.6)
Unemployed 29 (28.7)
Retired 6 (5.9)
Disabled 7 (6.9)
Other (housewife/student/no answer) 15 (14.8)
Education
None 9 (8.9)
Some school, no diploma 58 (57.4)
High school or general equivalency diploma 22 (21.8)
Trade/technical/vocational training 2 (2.0)
Undergraduate degree or higher 9 (8.9)
Annual household income, $
<10,000 50 (49.5)
10,000–50,000 40 (39.6)
No answer 11 (10.9)
Diabetes duration, y
0–1 15 (14.9)
2–5 17 (16.8)
6–9 27 (26.7)
≥10 41 (40.6)
Transportation to clinic
Drive oneself 34 (33.7)
Walk 7 (6.9)
Bus 37 (36.6)
Brought by someone 21 (20.8)
Abbreviations: SD, standard deviation.
a Values are number (percentage) unless otherwise indicated. Numbers may not add to 101 because of rounding.
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